Nabota 100UI

$68.90

Discover Nabota 100 units, a game-changing type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and officially approved by the U.S. Food and Drug Administration. Nabota, the first Korean botulinum toxin to break into the U.S. market, positions itself as an affordable alternative to Botox, offering the same potency without necessitating changes in handling practices for this potentially hazardous material.